Delivery Order SPE2DB24D2216-SPE2DB25FGNZS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Fluticasone Propionate 50 mcg spray (16 gm) with a ceiling value of $1,730.88. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete task under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16 GM units. This non-competitive award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery order under a larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,500.54 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16 grams) on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside provisions. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16-gram unit) valued at $1,396.90 under a firm fixed-price contract type. This delivery order, issued on August 19, 2025, represents a non-competitive set-aside and carries an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,331.36 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16GM units. The contract was awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order falls under a...
- The Defense Logistics Agency awarded a $1,062.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram spray (16 grams) on June 30, 2025, with an ultimate completion date of July 1, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for Fluticasone Propionate 50 micrograms spray in a 16-gram formulation, with a ceiling value of $1,736.20. This firm fixed-price delivery order, due for completion by September 22, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger...
- The Defense Logistics Agency has awarded a delivery order valued at $1,730.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16-gram units. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order was awarded on September 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in a 16-gram formulation. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,030.32 and is scheduled for completion by August 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement....
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNZSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Fluticasone Propionate 50 MCG Spray in 16GM units, with a firm fixed price ceiling value of $1,406.44. This non-set-aside competitive award is classified as a delivery order under a larger contract vehicle, with an ultimate completion date of June 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a single transaction under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries to the Defense Health Agency and other government healthcare entities, demonstrating its capability to fulfill federal medical requirements across multiple therapeutic domains through competitively awarded, firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/17/25 |